News

AddToAny

Google+ Facebook Twitter Twitter

3D human cell models

Medicines Discovery Catapult and the Medical Research Council Centre for Drug Safety Science at the University of Liverpool are collaborating.

They have agreed a memorandum of understanding to combine their academic and industry expertise in developing next generation 3D human cell models and creating robust cellular platforms.

Through the collaboration these will be available to UK drug discovery SMEs.

The first project to be undertaken under the new alliance will focus on the development of a next generation cardiac safety model. The human cell model will enable companies to measure a broader range of patient relevant toxicities in a single assay.

md.catapult.org.uk

Picture credit | Science Photo Library

Related Articles

p8-13-lungs-istock-166011791-.jpg

Lung cancers metabolise differently

Researchers have discovered that the two most common forms of lung cancer metabolise nutrients differently, revealing new vulnerabilities that could be exploited in future treatment for patients.

p10-13-news-neutrophil-white_blood_cell-science-photo-library-f0224299.jpg

Biomarker for bladder cancer

A new diagnostic technique has revealed a protein biomarker that accurately differentiates bladder cancer from benign inflammation.

p16-17-one-to-one-circuit-board-and-chip2.jpg

A cellular intranet

Professor Mark Evans explains his research into cellular networks that can be rapidly dismantled, reconfigured and rebuilt.

p30-35-big-story-technician-nanette-fishman-uses-a-needle-to-put-protein-sample-getty-161991309.png

War on cancer pt. 3

The final instalment of a short series, which briefly reviews the historical developments in cancer treatment, covering recent approaches, such as targeted therapy and genetic profiling. 

Top